PRAC relief for HPV vaccines
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has found no evidence to support a causal link between the marketed HPV vaccines and two rare conditions after a review of the latest scientific knowledge.